Durkin v. Sanofi-Aventis U.S. LLC et al
| MICHAEL DURKIN |
| Sanofi-Aventis U.S. LLC and REGENERON PHARMACEUTICALS, INC. |
| 2:2026cv00231 |
| February 4, 2026 |
| U.S. District Court for the Middle District of Florida |
| Sheri Polster Chappell |
| Nicholas P Mizell |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 1, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 19 NOTICE re 16 Notice of Hearing: A case management report does not have to be filed due to case being stayed. (WRW) |
Filing 18
ORDERED: The Joint Motion to Stay All Proceedings Pending Decision by the Judicial Panel on Multi-District Litigation (Doc. #17) is GRANTED. The parties shall file a status report within seven (7) days of the JPML's ruling on the Motion to Transfer, apprising the Court of the JPML's decision. Signed by Judge Sheri Polster Chappell on 3/30/2026. (AEH)
|
| Filing 17 Joint Unopposed Motion to Stay All Proceedings Pending Decision by the Judicial Panel on MultiDistrict Litigation by Sanofi-Aventis U.S. LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Text of Proposed Order)(Pertnoy, Jeffrey) Modified docket text on 3/27/2026 (JOS). |
| Filing 16 NOTICE of hearing: Rule 16(b) Conference set for 5/21/2026 at 10:00 AM in Zoom Video Conference before Magistrate Judge Nicholas P. Mizell. A case management report to be filed by 5/13/2026. Join ZoomGov Meeting: https://www.zoomgov.com/j/1604544449?pwd=YOQivYVxezPFbyApggdze2aytjogZ6.1; Meeting ID: 160 454 4449; Passcode: 544955(WRW) |
| Filing 15 DISCLOSURE STATEMENT under Rule 7.1, Federal Rules of Civil Procedure, and Local Rule 3.03 by Regeneron Pharmaceuticals, Inc.. (Clement, Anitra) |
| Filing 14 NOTICE of Appearance by Anitra R. Clement on behalf of Regeneron Pharmaceuticals, Inc. (Clement, Anitra) |
| Filing 13 ENTERED IN ERROR. Modified text on 3/23/2026 (BD). |
| Filing 12 Copy of Motion to Expedite Consideration of Motion to Transfer Case with the Multi-District Litigation Panel (LAW) |
| Filing 11 Copy of Motion to Transfer Case filed with the Multi-District Litigation Panel (ABM) |
| Filing 10 WAIVER of service returned executed on 2/23/2026 by Michael Durkin as to Regeneron Pharmaceuticals, Inc. (Williamson, George) Modified text on 2/24/2026 (CTR). |
| Filing 9 WAIVER of service returned executed on 2/20/2026 by Michael Durkin as to Sanofi-Aventis U.S. LLC. (Williamson, George) |
| Filing 8 NOTICE of Lead Counsel Designation by George T. Williamson on behalf of Michael Durkin. Lead Counsel: George T. Williamson. (Williamson, George) |
| Filing 7 NOTICE by Michael Durkin of filing of Plaintiff's Disclosure Statement (Williamson, George) |
| Filing 6 CIVIL Action Order Signed by All Divisional Judges on 2/6/2026. (WRW) |
| Filing 5 NOTICE of Local Rule 2.02(a), which states, "The first paper filed on behalf of a party must designate only one lead counsel who - unless the party changes the designation - remains lead counsel throughout the action." Counsel must file a Notice of Lead Counsel Designation identifying lead counsel. (Signed by Deputy Clerk). (CTR) |
| Filing 4 SUMMONS issued as to Regeneron Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC. (CTR) |
|
Filing 3
TEXT ORDER: Local Rule 3.03 requires that, with the first appearance, each party must file a disclosure statement using the standard form from the clerk or the court's website. Plaintiff failed to do so. By February 13, 2026, plaintiff must file his disclosure statement using the standard form, which can be found at: https://www.flmd.uscourts.gov/local-rules/rule-303-disclosure-statement. Signed by Magistrate Judge Nicholas P. Mizell on 2/6/2026. (TLP)
|
| Filing 2 NEW CASE ASSIGNED to Judge Sheri Polster Chappell and Magistrate Judge Nicholas P. Mizell. New case number: 2:26-cv-00231-SPC-NPM. (LAW) |
| Filing 1 COMPLAINT against Regeneron Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC with Jury Demand (Filing fee $405 receipt number AFLMDC-24422341) filed by Michael Durkin. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons, #3 Proposed Summons)(Williamson, George) Modified all caps text on 2/6/2026 (CTR). |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
